STRIT1
gene geneOn this page
Also known as DWORF
Summary
STRIT1 (small transmembrane regulator of ion transport 1, HGNC:52297) is a protein-coding gene on chromosome 3q25.2, encoding Sarcoplasmic/endoplasmic reticulum calcium ATPase regulator DWORF (P0DN84). Enhances the activity of ATP2A1/SERCA1 ATPase in sarcoplasmic reticulum by displacing ATP2A1/SERCA1 inhibitors, thereby acting as a key regulator of skeletal muscle activity.
Predicted to enable enzyme activator activity. Predicted to be involved in regulation of calcium ion transport and regulation of striated muscle contraction. Predicted to act upstream of or within positive regulation of ATPase-coupled calcium transmembrane transporter activity and positive regulation of calcium ion import. Predicted to be located in sarcoplasmic reticulum membrane.
Source: NCBI Gene 100507537 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001352129
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:52297 |
| Approved symbol | STRIT1 |
| Name | small transmembrane regulator of ion transport 1 |
| Location | 3q25.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DWORF |
| Ensembl gene | ENSG00000240045 |
| Ensembl biotype | protein_coding |
| OMIM | 616891 |
| Entrez | 100507537 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000489090
RefSeq mRNA: 1 — MANE Select: NM_001352129
NM_001352129
CCDS: CCDS87158
Canonical transcript exons
ENST00000489090 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001828305 | 155293620 | 155293683 |
| ENSE00001882056 | 155290940 | 155291038 |
| ENSE00001944442 | 155290227 | 155290846 |
Expression profiles
Bgee: expression breadth ubiquitous, 165 present calls, max score 99.67.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 1.8791 / max 907.2394, expressed in 69 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 45219 | 1.3087 | 45 |
| 45220 | 0.2411 | 34 |
| 45218 | 0.1646 | 16 |
| 45222 | 0.0756 | 25 |
| 45221 | 0.0663 | 24 |
| 45223 | 0.0227 | 11 |
Top tissues by expression
242 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| gastrocnemius | UBERON:0001388 | 99.67 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 99.54 | gold quality |
| tibialis anterior | UBERON:0001385 | 99.43 | gold quality |
| vastus lateralis | UBERON:0001379 | 99.42 | gold quality |
| quadriceps femoris | UBERON:0001377 | 99.40 | gold quality |
| deltoid | UBERON:0001476 | 99.22 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 99.16 | gold quality |
| biceps brachii | UBERON:0001507 | 99.03 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 98.91 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 98.77 | gold quality |
| muscle of leg | UBERON:0001383 | 97.59 | gold quality |
| body of tongue | UBERON:0011876 | 91.37 | gold quality |
| muscle tissue | UBERON:0002385 | 89.54 | gold quality |
| putamen | UBERON:0001874 | 86.38 | gold quality |
| tongue | UBERON:0001723 | 85.45 | gold quality |
| jejunal mucosa | UBERON:0000399 | 84.69 | gold quality |
| jejunum | UBERON:0002115 | 82.17 | gold quality |
| caudate nucleus | UBERON:0001873 | 75.95 | gold quality |
| superior surface of tongue | UBERON:0007371 | 75.17 | gold quality |
| apex of heart | UBERON:0002098 | 72.12 | gold quality |
| buccal mucosa cell | CL:0002336 | 71.09 | silver quality |
| heart left ventricle | UBERON:0002084 | 68.34 | gold quality |
| cardiac ventricle | UBERON:0002082 | 67.40 | gold quality |
| duodenum | UBERON:0002114 | 65.96 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 63.95 | silver quality |
| minor salivary gland | UBERON:0001830 | 62.65 | gold quality |
| lower lobe of lung | UBERON:0008949 | 61.75 | silver quality |
| mucosa of paranasal sinus | UBERON:0005030 | 61.34 | silver quality |
| mouth mucosa | UBERON:0003729 | 60.72 | gold quality |
| heart | UBERON:0000948 | 59.97 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 3)
- The transmembrane peptide DWORF activates SERCA2a via dual mechanisms. (PMID:33581112)
- Dwarf open reading frame (DWORF) is a direct activator of the sarcoplasmic reticulum calcium pump SERCA. (PMID:34075877)
- Inhibitory and stimulatory micropeptides preferentially bind to different conformations of the cardiac calcium pump. (PMID:35605666)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Strit1 | ENSMUSG00000103476 |
Protein
Protein identifiers
Sarcoplasmic/endoplasmic reticulum calcium ATPase regulator DWORF — P0DN84 (reviewed: P0DN84)
Alternative names: Dwarf open reading frame, Small transmembrane regulator of ion transport 1
All UniProt accessions (1): P0DN84
UniProt curated annotations — full annotation on UniProt →
Function. Enhances the activity of ATP2A1/SERCA1 ATPase in sarcoplasmic reticulum by displacing ATP2A1/SERCA1 inhibitors, thereby acting as a key regulator of skeletal muscle activity. Also enhances the activity of the ATP2A2/SERCA2 ATPase. Does not directly stimulate SERCA pump activity. Binds preferentially to the phosphorylated E1 and E2 conformational forms of ATP2A2 which predominate at high Ca(2+) concentrations during the systolic phase of the cardiac cycle. Competes with ATP2A2 inhibitor phospholamban (PLN) for binding to ATP2A2 and displaces PLN. Can activate ATP2A2 directly in the absence of PLN. Also enhances sarcoplasmic reticulum Ca(2+) uptake and myocyte contractility by displacing the SERCA inhibitory peptides sarcolipin (SLN) and myoregulin (MRLN).
Subunit / interactions. Homooligomer. Can also form heterooligomers with other sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) regulators ARLN, ERLN, PLN and SLN. Monomer. Interacts with ATP2A1/SERCA1; the interaction results in activation of ATP2A1. Interacts as a monomer with ATP2A2/SERCA2; the interaction results in activation of ATP2A2.
Subcellular location. Sarcoplasmic reticulum membrane.
Domain organisation. The transmembrane domain is sufficient to compete with phospholamban (PLN) for binding to ATP2A2.
RefSeq proteins (1): NP_001339058* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR044529 | DWORF | Family |
Pfam: PF22030
UniProt features (5 total): mutagenesis site 2, chain 1, transmembrane region 1, helix 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7MPA | SOLID-STATE NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DN84-F1 | 85.41 | 0.62 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 15 | significant reduction in binding to atp2a and reduced atp2a2 activation; when associated with a-22. |
| 22 | significant reduction in binding to atp2a and reduced atp2a2 activation; when associated with a-15. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 62 (showing top):
GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT, GOBP_CIRCULATORY_SYSTEM_PROCESS, GOBP_MULTICELLULAR_ORGANISMAL_MOVEMENT, GOBP_SKELETAL_MUSCLE_CONTRACTION, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS, GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT, GOBP_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION, GOBP_REGULATION_OF_MUSCLE_CONTRACTION, GOBP_MUSCLE_CONTRACTION, GOBP_CALCIUM_ION_IMPORT, GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT, GOBP_REGULATION_OF_CALCIUM_ION_IMPORT, GOBP_REGULATION_OF_CELLULAR_LOCALIZATION, GOBP_CARDIAC_MUSCLE_CELL_CONTRACTION
GO Biological Process (5): regulation of slow-twitch skeletal muscle fiber contraction (GO:0031449), positive regulation of calcium ion import (GO:0090280), positive regulation of cardiac muscle cell contraction (GO:0106134), regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901894), positive regulation of calcium ion import into sarcoplasmic reticulum (GO:1902082)
GO Molecular Function (2): enzyme activator activity (GO:0008047), protein binding (GO:0005515)
GO Cellular Component (3): sarcoplasmic reticulum membrane (GO:0033017), membrane (GO:0016020), sarcoplasmic reticulum (GO:0016529)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| positive regulation of calcium ion transport | 2 |
| regulation of twitch skeletal muscle contraction | 1 |
| slow-twitch skeletal muscle fiber contraction | 1 |
| calcium ion import | 1 |
| regulation of calcium ion import | 1 |
| cardiac muscle cell contraction | 1 |
| regulation of cardiac muscle cell contraction | 1 |
| positive regulation of actin filament-based movement | 1 |
| P-type calcium transporter activity | 1 |
| regulation of transmembrane transporter activity | 1 |
| regulation of ATP-dependent activity | 1 |
| positive regulation of intracellular transport | 1 |
| regulation of calcium ion import into sarcoplasmic reticulum | 1 |
| calcium ion import into sarcoplasmic reticulum | 1 |
| catalytic activity | 1 |
| enzyme regulator activity | 1 |
| molecular function activator activity | 1 |
| binding | 1 |
| endoplasmic reticulum membrane | 1 |
| sarcoplasmic reticulum | 1 |
| bounding membrane of organelle | 1 |
| cellular anatomical structure | 1 |
| endoplasmic reticulum | 1 |
| sarcoplasm | 1 |
Protein interactions and networks
STRING
158 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| STRIT1 | MRLN | P0DMT0 | 871 |
| STRIT1 | SLN | O00631 | 848 |
| STRIT1 | ERLN | P0DI80 | 729 |
| STRIT1 | ARLN | Q8WVX3 | 684 |
| STRIT1 | SPAAR | A0A1B0GVQ0 | 666 |
| STRIT1 | MTLN | Q8NCU8 | 545 |
| STRIT1 | MYMX | A0A1B0GTQ4 | 534 |
| STRIT1 | SMIM38 | A0A286YFK9 | 520 |
| STRIT1 | NBDY | A0A0U1RRE5 | 507 |
| STRIT1 | TMDD1 | P0DPE3 | 506 |
| STRIT1 | FAM240C | A0A1B0GVR7 | 479 |
| STRIT1 | SMIM30 | A4D0T7 | 419 |
| STRIT1 | SMIM28 | A0A1B0GU29 | 417 |
| STRIT1 | ATP2A1 | O14983 | 377 |
| STRIT1 | SMIM22 | K7EJ46 | 353 |
IntAct
138 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| STRIT1 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | SPNS3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | TMEM101 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | PDZK1IP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | HSD17B13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | IFNGR2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | TMEM51 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | SLC14A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | MSMO1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | KCNJ6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | SCN3B | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | ANKS6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | MOG | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | MFF | psi-mi:“MI:0915”(physical association) | 0.560 |
| BSCL2 | STRIT1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | STX1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | STX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | JPH1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | EDA2R | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | TMEM237 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | CMTM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
ESM2 similar proteins: A0A1B0GWH6, A0A7H0DN68, A0A7H0DNB3, A0T0B1, A0T0B4, A0T0P6, A2BVK2, A4ZUB9, A4ZUC7, A5A617, B7K767, C0HJH3, C0HJH4, C7J0R5, O00631, O78448, P0C2G8, P0CAJ2, P0CAJ3, P0CAJ4, P0CK21, P0CK22, P0DN84, P0DPN0, P0DPO4, P0DPO8, P0DTF1, P0DTI0, P11339, P15911, P30396, P37256, P48109, P49487, P49516, P64442, P64443, P64444, P9WEJ6, Q06J23
Diamond homologs: P0DN83, P0DN84
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
219 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:155290979:C:G | G25R | 0.971 |
| 3:155290988:A:G | W22R | 0.970 |
| 3:155290988:A:T | W22R | 0.970 |
| 3:155290991:C:G | G21R | 0.948 |
| 3:155290978:C:T | G25D | 0.941 |
| 3:155290976:A:G | C26R | 0.934 |
| 3:155290969:A:T | I28K | 0.932 |
| 3:155290990:C:T | G21D | 0.930 |
| 3:155290969:A:C | I28R | 0.899 |
| 3:155290999:A:T | L18H | 0.870 |
| 3:155291002:A:T | L17H | 0.868 |
| 3:155290950:G:C | F34L | 0.863 |
| 3:155290950:G:T | F34L | 0.863 |
| 3:155290952:A:G | F34L | 0.863 |
| 3:155291002:A:C | L17R | 0.857 |
| 3:155290981:A:T | V24E | 0.844 |
| 3:155290996:A:C | L19R | 0.830 |
| 3:155290954:A:T | V33D | 0.823 |
| 3:155290999:A:G | L18P | 0.818 |
| 3:155290999:A:C | L18R | 0.811 |
| 3:155291011:A:T | V14D | 0.784 |
| 3:155290986:C:A | W22C | 0.775 |
| 3:155290986:C:G | W22C | 0.775 |
| 3:155290957:A:T | V32D | 0.760 |
| 3:155290966:A:T | M29K | 0.757 |
| 3:155290984:A:T | I23N | 0.753 |
| 3:155290966:A:C | M29R | 0.748 |
| 3:155290996:A:G | L19P | 0.713 |
| 3:155291008:G:T | P15H | 0.695 |
| 3:155290993:A:T | I20N | 0.671 |
dbSNP variants (sampled 300 via entrez): RS1000710615 (3:155292903 G>A,T), RS1001358352 (3:155295247 T>A,C), RS1001515847 (3:155292261 G>A), RS1001592975 (3:155291844 A>G), RS1001851238 (3:155293636 T>C), RS1001924767 (3:155293203 G>A), RS1002113987 (3:155291041 T>C), RS1002457312 (3:155292520 C>T), RS1003074126 (3:155292068 A>C,T), RS1003457562 (3:155293994 A>G), RS1003541904 (3:155294993 T>C,G), RS1003573240 (3:155294687 A>G,T), RS1004718736 (3:155295196 A>G), RS1004787905 (3:155294058 C>T), RS1005031322 (3:155294666 C>A,T)
Disease associations
OMIM: gene MIM:616891 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Sunitinib | increases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.